Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Ramsay Health Care (RMSYF – Research Report), Glass House Brands (GLASF – Research Report) and RemeGen Co. Ltd. Class H (HK:9995 – Research Report).
Ramsay Health Care (RMSYF)
J.P. Morgan analyst David Low downgraded Ramsay Health Care to Sell on March 28 and set a price target of A$50.00. The company’s shares closed last Thursday at $35.25.
According to TipRanks.com, Low is a 2-star analyst with an average return of
Currently, the analyst consensus on Ramsay Health Care is a Hold with an average price target of $37.82.
See Insiders’ Hot Stocks on TipRanks >>
Glass House Brands (GLASF)
Canaccord Genuity analyst Robert Burleson maintained a Buy rating on Glass House Brands on March 28 and set a price target of $9.00. The company’s shares closed last Wednesday at $8.40, close to its 52-week high of $8.65.
Burleson has an average return of
According to TipRanks.com, Burleson is ranked #690 out of 8791 analysts.
Glass House Brands has an analyst consensus of Moderate Buy, with a price target consensus of $9.00.
RemeGen Co. Ltd. Class H (HK:9995)
In a report issued on March 28, Yang Huang from J.P. Morgan maintained a Hold rating on RemeGen Co. Ltd. Class H, with a price target of HK$28.00. The company’s shares closed yesterday at HK$29.30.
According to TipRanks.com, Huang is ranked #5591 out of 8791 analysts.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for RemeGen Co. Ltd. Class H with a HK$34.77 average price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on RMSYF:
